Patricia van Dijck
Public Communications Contact bei GSK Belux
Profil
Patricia van Dijck is currently the Director-Market Access & Public Affairs at GSK Belux since 2018.
Prior to this, she worked as an Independent Director at Mithra Pharmaceuticals SA from 2021 to 2023, as a Medical Director at Lundbeck SA from 1998 to 2007, and as the Head-Market Access & Public Affairs at Novartis Belux.
She holds a doctorate degree from the Université Catholique de Louvain.
Aktive Positionen von Patricia van Dijck
| Unternehmen | Position | Beginn |
|---|---|---|
| GSK Belux | Public Communications Contact | 01.01.2018 |
Ehemalige bekannte Positionen von Patricia van Dijck
| Unternehmen | Position | Ende |
|---|---|---|
| MITHRA PHARMACEUTICALS S.A. | Chairman | 01.06.2021 |
| Novartis Belux | Public Communications Contact | - |
Lundbeck SA
 Lundbeck SA Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck SA is a Belgian company founded in 2000. The private company is based in Brussels, Belgium. The company's description mentions that a migraine attack is a severe headache, usually present with other symptoms, that stops a person from going about their daily life. | Chief Executive Officer | - |
Ausbildung von Patricia van Dijck
| Université Catholique de Louvain | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MITHRA PHARMACEUTICALS S.A. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Lundbeck SA
Lundbeck SA Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck SA is a Belgian company founded in 2000. The private company is based in Brussels, Belgium. The company's description mentions that a migraine attack is a severe headache, usually present with other symptoms, that stops a person from going about their daily life. | Health Technology |
| Novartis Belux | |
| GSK Belux |
